IL6 and schizophrenia: Dennison et al reported higher levels of IL-6 in patients with schizophrenia who reported exposure to CM compared to patients with schizophrenia who did not report maltreatment and healthy controls (mean IL-6: 2.14pg/ml (SD = 0.318), 1.048pg/ml (SD = 0.172), 1.092pg/ml (SD = 0.296) respectively; F = 4,258, df = 143, p<0.05), in an ANOVA that did not adjust for covariates [60].